Cargando…
In vivo human keyhole limpet hemocyanin challenge in early phase drug development: A systematic review
Experimental exposure of healthy volunteers to the T‐cell dependent neoantigen keyhole limpet hemocyanin (KLH) permits the evaluation of immunomodulatory investigational medicinal product (IMP) pharmacology prior to the recruitment of patient populations. Despite widespread use, no standardized appr...
Autores principales: | Drennan, Philip G., Karponis, Dimitrios, Richards, Duncan, Coles, Mark, Fullerton, James N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014697/ https://www.ncbi.nlm.nih.gov/pubmed/36420645 http://dx.doi.org/10.1111/cts.13457 |
Ejemplares similares
-
Human monoclonal anti-keyhole limpet hemocyanin antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a keyhole limpet hemocyanin-immune individual
Publicado: (1982) -
Immunization of mice with the self-peptide ACBP coupled to keyhole limpet hemocyanin
por: Montégut, Léa, et al.
Publicado: (2022) -
Schistosoma mansoni shares a protective carbohydrate epitope with keyhole limpet hemocyanin
Publicado: (1987) -
Keyhole limpet hemocyanin induces innate immunity via Syk and Erk phosphorylation
por: Yasuda, Kyoko, et al.
Publicado: (2016) -
Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients
por: Wimmers, Florian, et al.
Publicado: (2017)